Kidney Cancer
-15%
portes grátis
Kidney Cancer
Principles and Practice
Jonasch, Eric; Lara, Primo N.
Springer International Publishing AG
10/2016
402
Mole
Inglês
9783319342528
15 a 20 dias
1057
Descrição não disponível.
Part 1: Epidemiology and Biology
Epidemiology of Kidney Cancer.- Pathological Classification.- Molecular Biology of Kidney Cancer.- Biomarkers for Kidney Cancer.- Genetic Heterogeneity of Kidney Cancer.- Metabolic Basis of Kidney Cancer.
Part 2: Clinical Considerations
Clinical Presentation and Staging.- Hereditary Kidney Cancer.
Part 3: Surgical and Local Control Modalities
Surgical Approaches to Early Stage Kidney Cancer.- Cytoreductive Nephrectomy.- Metastasectomy.- Energy Ablative Techniques in Kidney Cancer.- The Role of Radiation Therapy in Kidney Cancer.
Part 4: Systemic Therapy Considerations
Adjuvant Systemic Therapy.- Cytokines and Vaccine Therapy.- PD1 and PDL1 Targeted Therapy.- Angiogenesis Inhibitor Therapy.- The Role of mTOR inhibitors and PI3K Pathway Blockade.- Sequential versus Combination Strategies.- Presurgical Therapy in Kidney Cancer.- Toxicity Management for Patients on Targeted Therapies.- Emerging Agents in Kidney Cancer.
Epidemiology of Kidney Cancer.- Pathological Classification.- Molecular Biology of Kidney Cancer.- Biomarkers for Kidney Cancer.- Genetic Heterogeneity of Kidney Cancer.- Metabolic Basis of Kidney Cancer.
Part 2: Clinical Considerations
Clinical Presentation and Staging.- Hereditary Kidney Cancer.
Part 3: Surgical and Local Control Modalities
Surgical Approaches to Early Stage Kidney Cancer.- Cytoreductive Nephrectomy.- Metastasectomy.- Energy Ablative Techniques in Kidney Cancer.- The Role of Radiation Therapy in Kidney Cancer.
Part 4: Systemic Therapy Considerations
Adjuvant Systemic Therapy.- Cytokines and Vaccine Therapy.- PD1 and PDL1 Targeted Therapy.- Angiogenesis Inhibitor Therapy.- The Role of mTOR inhibitors and PI3K Pathway Blockade.- Sequential versus Combination Strategies.- Presurgical Therapy in Kidney Cancer.- Toxicity Management for Patients on Targeted Therapies.- Emerging Agents in Kidney Cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cancer Biology;Kidney Cancer;Nephrology;Oncology;Renal Cell Cancer
Part 1: Epidemiology and Biology
Epidemiology of Kidney Cancer.- Pathological Classification.- Molecular Biology of Kidney Cancer.- Biomarkers for Kidney Cancer.- Genetic Heterogeneity of Kidney Cancer.- Metabolic Basis of Kidney Cancer.
Part 2: Clinical Considerations
Clinical Presentation and Staging.- Hereditary Kidney Cancer.
Part 3: Surgical and Local Control Modalities
Surgical Approaches to Early Stage Kidney Cancer.- Cytoreductive Nephrectomy.- Metastasectomy.- Energy Ablative Techniques in Kidney Cancer.- The Role of Radiation Therapy in Kidney Cancer.
Part 4: Systemic Therapy Considerations
Adjuvant Systemic Therapy.- Cytokines and Vaccine Therapy.- PD1 and PDL1 Targeted Therapy.- Angiogenesis Inhibitor Therapy.- The Role of mTOR inhibitors and PI3K Pathway Blockade.- Sequential versus Combination Strategies.- Presurgical Therapy in Kidney Cancer.- Toxicity Management for Patients on Targeted Therapies.- Emerging Agents in Kidney Cancer.
Epidemiology of Kidney Cancer.- Pathological Classification.- Molecular Biology of Kidney Cancer.- Biomarkers for Kidney Cancer.- Genetic Heterogeneity of Kidney Cancer.- Metabolic Basis of Kidney Cancer.
Part 2: Clinical Considerations
Clinical Presentation and Staging.- Hereditary Kidney Cancer.
Part 3: Surgical and Local Control Modalities
Surgical Approaches to Early Stage Kidney Cancer.- Cytoreductive Nephrectomy.- Metastasectomy.- Energy Ablative Techniques in Kidney Cancer.- The Role of Radiation Therapy in Kidney Cancer.
Part 4: Systemic Therapy Considerations
Adjuvant Systemic Therapy.- Cytokines and Vaccine Therapy.- PD1 and PDL1 Targeted Therapy.- Angiogenesis Inhibitor Therapy.- The Role of mTOR inhibitors and PI3K Pathway Blockade.- Sequential versus Combination Strategies.- Presurgical Therapy in Kidney Cancer.- Toxicity Management for Patients on Targeted Therapies.- Emerging Agents in Kidney Cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
